|
||||||||
|
|
|
|
|
|
|
||
|
|
|||||||
 |
  |
|||
Read about the latest news from qd Solutions. qd Tips: Clinical Trials News: |
Acologix Presents Data on Cartilage Regeneration by AC-100 at the 56th Annual Meeting of the Orthopaedic Research SocietyHAYWARD, Calif., March 6 /PRNewswire/ -- Acologix, Inc., a privately held biopharmaceutical company, today announced the results of its latest preclinical study demonstrating that AC-100, its therapeutic product candidate derived from an endogenous...
Posted on 9 March 2010 | 9:21 pm Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase InhibitorsREDWOOD CITY, Calif., March 8 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced the publication of positive results from a large international study which demonstrated that the Oncotype DX® breast cancer...
Posted on 9 March 2010 | 7:55 pm New Data Presented at American Burn Association's Annual Meeting Support Safety Profile of RECOTHROM Thrombin, Topical (Recombinant) in Pediatric PatientsSEATTLE--(BUSINESS WIRE)--Mar 9, 2010 - ZymoGenetics, Inc. (NASDAQ:ZGEN), today announced the presentation of safety and immunogenicity data among pediatric burn patients at the 42nd Annual Meeting of the American Burn Association in Boston, MA. The...
Posted on 9 March 2010 | 7:33 pm Mayo Researchers Link Obesity to Worse Outcome in Patients Being Treated for Colon CancerResearchers say that obesity leads to more aggressive colon cancer and that the risk differs between men and women ROCHESTER, Minn.--(BUSINESS WIRE)--Mar 9, 2010 - It's long been known that obesity is linked to increased risk of developing...
Posted on 9 March 2010 | 7:11 pm BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS MeetingData Demonstrates rhPDGF-BB, in Combination with Tissue Specific Matrix Materials, Promotes Healing in Achilles and Rotator Cuff Tears FRANKLIN, Tenn.--(BUSINESS WIRE)--Mar 9, 2010 - BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced...
Posted on 9 March 2010 | 7:05 pm |
|